0001665160-22-003105.txt : 20221222 0001665160-22-003105.hdr.sgml : 20221222 20221222120915 ACCESSION NUMBER: 0001665160-22-003105 CONFORMED SUBMISSION TYPE: C/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20221222 DATE AS OF CHANGE: 20221222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Fisher Wallace Laboratories, Inc. CENTRAL INDEX KEY: 0001787792 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 208131183 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: C/A SEC ACT: 1933 Act SEC FILE NUMBER: 020-31014 FILM NUMBER: 221480936 BUSINESS ADDRESS: STREET 1: 515 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 917-930-4332 MAIL ADDRESS: STREET 1: 630 FLUSHING AVENUE, SUITE #104 CITY: BROOKLYN STATE: NY ZIP: 11206 C/A 1 primary_doc.xml C/A 0001787792 XXXXXXXX 020-31014 LIVE false false false true Issuer is extending campaign end date. Fisher Wallace Laboratories, Inc. Corporation DE 08-23-2019 630 FLUSHING AVENUE, SUITE #104 BROOKLYN NY 11206 www.fisherwallace.com N StartEngine Capital, LLC 0001665160 007-00007 Up to 9% percent Three percent (3%) of securities of the total amount of investments raised in the offering, along the same terms as investors. Other Class B Non-Voting Common Stock 1135 8.81000 N/A 9999.35 Y Other At issuer's discretion, with priority given to StartEngine Owners 1844761.14 02-20-2023 12.00 1999403.00 853359.00 1929380.00 695749.00 0.00 2302.00 471468.00 725122.00 576525.00 620416.00 4230290.00 4250866.00 623703.00 970761.00 250.00 1597.00 -3262291.00 -1823732.00 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY Fisher Wallace Laboratories, Inc. Kelly Roman CEO, Director Kelly Roman CEO, Director 12-22-2022 Charles Fisher Chairman, CFO, Director, Secretary 12-22-2022 Simon Webster Director 12-22-2022